Optimization and characterization of tRNA-shRNA expression constructs

Nucleic Acids Research

Volumn 35, Issue 8, 2007, Pages 2620-2628

  Scherer, Lisa J ^a   Frank, Richard ^a   Rossi, John J ^a  

^a CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LYSINE TRANSFER RNA; RIBONUCLEASE; SHORT HAIRPIN RNA; SMALL INTERFERING RNA; AMINOACYL TRANSFER RNA; REV PROTEIN; TRANSACTIVATOR PROTEIN; TRNA, LYSINE; TRNA, LYSINE-; UNCLASSIFIED DRUG; UNTRANSLATED RNA;

ARTICLE; CHIMERA; CONTROLLED STUDY; GENE CASSETTE; GENE EXPRESSION; GENETIC ANALYSIS; HUMAN; HUMAN CELL; NORTHERN BLOTTING; PLASMID; PRIORITY JOURNAL; PROMOTER REGION; RNA INTERFERENCE; BIOSYNTHESIS; CELL LINE; CHEMISTRY; GENE VECTOR; GENETICS; HUMAN IMMUNODEFICIENCY VIRUS 1; METABOLISM; MOLECULAR GENETICS; NUCLEOTIDE SEQUENCE;

MAMMALIA;

BASE SEQUENCE; CELL LINE; GENE PRODUCTS, REV; GENE PRODUCTS, TAT; GENETIC VECTORS; HIV-1; HUMANS; MOLECULAR SEQUENCE DATA; PROMOTER REGIONS (GENETICS); RNA INTERFERENCE; RNA, SMALL INTERFERING; RNA, TRANSFER, AMINO ACYL; RNA, UNTRANSLATED;

EID: 34250357616     PISSN: 03051048     EISSN: 13624962     Source Type: Journal    
DOI: 10.1093/nar/gkm103     Document Type: Article

References (51)

1. Morris, K.V. and Rossi, J.J. (2006) Lentiviral-mediated delivery of siRNAs for antiviral therapy. Gene Ther., 13, 553-558.
2. Rossi, J.J. (2006) RNAi as a treatment for HIV-1 infection. Biotechniques, 40, s25-s29.
3. Nekhai, S, and Jerebtsova, M. (2006) Therapies for HIV with RNAi. Curr. Opin. Mol. Ther., 8, 52-61.
4. Cullen, B.R. (2005) Does RNA interference have a future as a treatment for HIV-1 induced disease? AIDS Rev., 7, 22-25.
5. Bagasra, O. (2005) RNAi as an antiviral therapy. Expert. Opin. Biol. Ther., 5, 1463-1474.
6. Nielsen, M.H., Pedersen, F.S. and Kjems, J. (2005) Molecular strategies to inhibit HIV-1 replication. Retrovirology, 2, 10.
7. Yeung, M.L., Bennasser, Y., Le, S.Y. and Jeang, K.T. (2005) siRNA, miRNA and HIV: Promises and challenges. Cell Res., 15, 935-946.
8. Grimm, D., Streetz, K.L., Jopling, C.L., Storm, T.A., Pandey, K., Davis, C.R., Marion, P., Salazar, F. and Kay, M.A. (2006) Fatality in mice due to oversaturation of cellular microRNA/short hairpin RNA pathways. Nature, 441, 537-541.
9. An, D.S., Qin, F.X., Auyeung, V.C., Mao, S.H., Kung, S.K., Baltimore, D. and Chen, I.S. (2006) Optimization and functional effects of stable short hairpin RNA expression in primary human lymphocytes via lentiviral vectors, Mol. Ther., 14, 494-504.
10. Lee, N.S., Dohjima, T., Bauer, G., Li, H., Li, M.J., Ehsani, A., Salvaterra, P. and Rossi, J. (2002) Expression of small interfering RNAs targeted against HIV-1 rev transcripts in human cells. Nat. Biotechnol., 20, 500-505.
11. Scherer, L.J., Yildiz, Y., Kim, J., Cagnon, L., Heale, B. and Rossi, J.J. (2004) Rapid assessment of anti-HIV siRNA efficacy using PCR-derived Pol III shRNA cassettes. Mol. Ther., 10, 597-603.
12. Westaway, S.K., Cagnon, L., Chang, Z., Li, S., Li, H., Larson, G.P., Zaia, J.A. and Rossi, J.J. (1998) Virion encapsidation of tRNA(3Lys)-ribozyme chimeric RNAs inhibits HIV infection. Antisense Nucleic Acid Drug. Dev., 8, 185-197.
13. Lowe, T.M. and Eddy, S.R. (1997) tRNAscan-SE: A program for improved detection of transfer RNA genes in genomic sequence. Nucleic Acids Res., 25, 955-964.
14. Hopper, A.K. and Phizicky, E.M. (2003) tRNA transfers to the limelight. Genes Dev., 17, 162-180.
15. Mohan, A., Whyte, S., Wang, X., Nashimoto, M. and Levinger, L. (1999) The 3′ end CCA of mature tRNA is an antideterminant for eukaryotic 3′-tRNase. RNA, 5, 245-256.
16. Nashimoto, M. (1997) Distribution of both lengths and 5′ terminal nucleotides of mammalian pre-tRNA 3′ trailers reflects properties of 3′ processing endoribonuclease. Nucleic Acids Res., 25, 1148-1154.
17. Zareen, N., Hopkinson, A. and Levinger, L. (2006) Residues in two homology blocks on the amino side of the tRNase Z His domain contribute unexpectedly to pre-tRNA 3′ end processing. RNA, 12, 1104-1115.
18. Chen, B.K., Saksela, K., Andino, R. and Baltimore, D. (1994) Distinct modes of human immunodeficiency virus type 1 proviral latency revealed by superinfection of nonproductively infected cell lines with recombinant luciferase-encoding viruses. J. Virol., 68, 654-660.
19. Connor, R.I., Chen, B.K., Choe, S. and Landau, N.R. (1995) Vpr is required for efficient replication of human immunodeficiency virus type-1 in mononuclear phagocytes. Virology, 206, 935-944.
20. Evans, D., Marquez, S.M. and Pace, N.R. (2006) RNase P: Interface of the RNA and protein worlds. Trends Biochem. Sci., 31, 333-341.
21. Kirsebom, L.A. (2002) RNase P RNA-mediated catalysis. Biochem. Soc. Trans., 30, 1153-1158.
22. Jarrous, N. (2002) Human ribonuclease P: Subunits, function, and intranuclear localization. RNA, 8, 1-7.
23. Xiao, S., Scott, F., Fierke, C.A. and Engelke, D.R. (2002) Eukaryotic ribonuclease P: A plurality of ribonucleoprotein enzymes. Annu. Rev. Biochem., 71, 165-189.
24. Vogel, A., Schilling, O., Spath, B. and Marchfelder, A. (2005) The tRNase Z family of proteins: Physiological functions, substrate specificity and structural properties. Biol. Chem., 386, 1253-1264.
25. Levinger, L., Morl, M. and Florentz, C. (2004) Mitochondrial tRNA 3′ end metabolism and human disease. Nucleic Acids Res., 32, 5430-5441.
26. Morl, M. and Marchfelder, A. (2001) The final cut. The importance of tRNA 3′-processing. EMBO Rep., 2, 17-20.
27. Weiner, A.M. (2004) tRNA maturation: RNA polymerization without a nucleic acid template. Curr. Biol., 14, R883-R885.
28. Helm, M. (2006) Post-transcriptional nucleotide modification and alternative folding of RNA. Nucleic Acids Res., 34, 721-733.
29. Geslain, R. and Ribas de Pouplana, L. (2004) Regulation of RNA function by aminoacylation and editing? Trends Genet., 20, 604-610.
30. Engelke, D.R. and Hopper, A.K. (2006) Modified view of tRNA: Stability amid sequence diversity. Mol. Cell., 21, 144-145.
31. Nakanishi, K. and Nureki, O. (2005) Recent progress of structural biology of tRNA processing and modification. Mol. Cells., 19 157-166.
32. Tavtigian, S.V., Simard, J., Teng, D.H., Abtin, V., Baumgard, M., Beck, A., Camp, N.J., Carillo, A.R., Chen, Y. et al. (2001) A candidate prostate cancer susceptibility gene at chromosome 17p. Nat. Genet. 27, 172-180.
33. Schiffer, S., Rosch, S. and Marchfelder, A. (2002) Assigning a function to a conserved group of proteins: The tRNA 3′-processing enzymes. EMBO J., 21, 2769-2777.
34. Takaku, H., Minagawa, A., Takagi, M. and Nashimoto, M. (2003) A candidate prostate cancer susceptibility gene encodes tRNA 3′ processing endoribonuclease. Nucleic Acids Res., 31, 2272-2278.
35. Yan, H., Zareen, N. and Levinger, L. (2006) Naturally occurring mutations in human mitochondrial pre-tRNASer(UCN) can affect the transfer ribonuclease Z cleavage site, processing kinetics, and substrate secondary structure. J. Biol. Chem., 281, 3926-3935.
36. Dubrovsky, E.B., Dubrovskaya, V.A., Levinger, L., Schiffer, S. and Marchfelder, A. (2004) Drosophila RNase Z processes mitochondrial and nuclear pre-tRNA 3′ ends in vivo. Nucleic Acids Res., 32, 255-262.
37. Levinger, L., Oestreich, I., Florentz, C. and Morl, M. (2004) A pathogenesis-associated mutation in human mitochondrial tRNALeu(UUR) leads to reduced 3′-end processing and CCA addition. J. Mol. Biol. 337, 535-544.
38. Levinger, L., Giege, R. and Florentz, C. (2003) Pathology-related substitutions in human mitochondrial tRNA(Ile) reduce precursor 3′ end processing efficiency in vitro. Nucleic Acids Res., 31, 1904-1912.
39. Levinger, L., Jacobs, O. and James, M. (2001) In vitro 3′-end endonucleolytic processing defect in a human mitochondrial tRNA(Ser(UCN)) precursor with the U7445C substitution, which causes non-syndromic deafness. Nucleic Acids Res., 29, 4334-4340.
40. Nashimoto, M. (2000) Anomalous RNA substrates for mammalian tRNA 3′ processing endoribonuclease. FEBS Lett., 472, 179-186.
41. Helm, M., Brule, H., Friede, D., Giege, R., Putz, D. and Florentz, C. (2000) Search for characteristic structural features of mammalian mitochondrial tRNAs. RNA, 6, 1356-1379.
42. Nashimoto, M., Geary, S., Tamura, M. and Kaspar, R. (1998) RNA heptamers that direct RNA cleavage by mammalian tRNA 3′ processing endoribonuclease. Nucleic Acids Res., 26, 2565-2572.
43. Tamura, M., Nashimoto, C., Miyake, N., Daikuhara, Y., Ochi, K. and Nashimoto, M. (2003) Intracellular mRNA cleavage by 3′ tRNase under the direction of 2′-O-methyl RNA heptamers. Nucleic Acids Res., 31, 4354-4360.
44. Habu, Y., Miyano-Kurosaki, N., Kitano, M., Endo, Y., Yukita, M., Ohira, S., Takaku, H. and Nashimoto, M. (2005) Inhibition of HIV-1 gene expression by retroviral vector-mediated small-guide RNAs that direct specific RNA cleavage by tRNase ZL. Nucleic Acids Res., 33, 235-243.
45. Yukita, M., Kitano, M., Miyano-Kurosaki, N., Takeuchi, H., Nashimoto, M. and Takaku, H. (2002) RNA cleavage by a mammalian tRNA 3′ processing endoribonuclease (3′tRNase) reduces HIV-1 expression. Nucleic Acids Res. Suppl., (Supp 2), 297-298.
46. Takaku, H., Minagawa, A., Takagi, M. and Nashimoto, M. (2004) A novel 4-base-recognizing RNA cutter that can remove the single 3′ terminal nucleotides from RNA molecules. Nucleic Acids Res., 32, e9l.
47. Nakashima, A., Takaku, H., Shibata, H.S., Negishi, Y., Takagi, M., Tamura, M. and Nashimoto, M. (2007) Gene silencing by the tRNA maturase tRNase Z(L) under the direction of small-guide RNA. Gene Ther, 41, 78-85.
48. Kawasaki, H. and Taira, K. (2003) Short hairpin type of dsRNAs that are controlled by tRNA(Val) promoter significantly induce RNAi-mediated gene silencing in the cytoplasm of human cells. Nucleic Acids Res., 31, 700-707.
49. Watanabe, T., Onuki, R., Yamashita, S., Taira, K. and Sugiyama, Y. (2005) Construction of a functional transporter analysis system using MDR1 knockdown Caco-2 cells. Pharm Res., 22, 1287-1293.
50. Kim, V.N. and Nam, J.W. (2006) Genomics of microRNA. Trends Genet, 22, 165-173.
51. Han, J., Lee, Y., Yeom, K.H., Nam, J.W., Heo, I., Rhee, J.K., Sohn, S.Y., Cho,Y., Zhang, B.T. et al. (2006) Molecular basis for the recognition of primary microRNAs by the drosha-DGCR8 complex. Cell 125, 887-901.